Elevated YTHDF2 expression was associated with decreased survival of all diffuse glioma and GBM patients in both the Chinese Glioma Genome Atlas (CGGA) and The Cancer Genome Atlas (TCGA) datasets. The gene discussed is YTHDF2; the disease is central nervous system cancer.